Literature DB >> 19715459

Rhabdovirus evasion of the interferon system.

Martina Rieder1, Karl-Klaus Conzelmann.   

Abstract

The family Rhabdoviridae contains important pathogens of humans, livestock, and crops, including the insect-transmitted vesicular stomatitis virus (VSV) and the neurotropic rabies virus (RV), which is directly transmitted between mammals. In spite of a highly similar organization of RNA genomes, proteins, and virus particles, cell biology of VSV and RV is divergent in several aspects, particularly with respect to their interplay with the cellular host defense. While infection with both rhabdoviruses is recognized via viral triphosphate RNAs by the cytoplasmic RNA helicase/translocase RIG-I, the viral counteractions to limit the response are contrasting. VSV infection is characterized by a rapid general shutdown of host gene expression and severe cytopathic effects, due to multiple activities of the matrix (M) protein affecting host polymerase functions and mRNA nuclear export, and by rapid and high-level virus replication. In contrast, RV spread and transmission relies on preserving the integrity of host cells, particularly of neurons. While a general cell shutdown by RV M is not observed, RV phosphoprotein (P) has developed independent functions to interfere with activation of IRFs and with STAT signaling. The molecular mechanisms employed are different from those of the paramyxovirus P gene products serving similar functions, and illustrate evolution of IFN antagonists to specifically support virus survival in the natural niches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715459     DOI: 10.1089/jir.2009.0068

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  40 in total

1.  The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection.

Authors:  Jayant V Rajan; David Rodriguez; Edward A Miao; Alan Aderem
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Chemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection.

Authors:  Michael L Vetter; Mary A Rodgers; Matthew P Patricelli; Priscilla L Yang
Journal:  ACS Chem Biol       Date:  2012-10-02       Impact factor: 5.100

Review 3.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

4.  Critical Role of K1685 and K1829 in the Large Protein of Rabies Virus in Viral Pathogenicity and Immune Evasion.

Authors:  Dayong Tian; Zhaochen Luo; Ming Zhou; Mingming Li; Lan Yu; Chong Wang; Jiaolong Yuan; Fang Li; Bin Tian; Baokun Sui; Huanchun Chen; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

6.  Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.

Authors:  Justin C Paglino; Wells Andres; Anthony N van den Pol
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1β release in murine dendritic cells.

Authors:  Tessa M Lawrence; Andrew W Hudacek; Marcel R de Zoete; Richard A Flavell; Matthias J Schnell
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.

Authors:  Christina D Steel; Kimberly Breving; Susan Tavakoli; Woong-Ki Kim; Larry D Sanford; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2013-12-11       Impact factor: 3.478

Review 9.  The emerging role of oncolytic virus therapy against cancer.

Authors:  Luke Russell; Kah-Whye Peng
Journal:  Chin Clin Oncol       Date:  2018-04

10.  CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.

Authors:  Roberto Alfonso; Ariel Rodriguez; Paloma Rodriguez; Thomas Lutz; Amelia Nieto
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.